Answer
Female patients of childbearing potential should use effective contraception throughout Ziihera (zanidatamab) treatment and for 4 months after the last dose.
Sources for this answer
- Ziihera 300 mg powder for concentrate for solution for infusionJazz Pharmaceuticals Research UK Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 1Document updated
Sources checked